Trial Outcomes & Findings for Community Support Program for Lung Cancer Screening Volume II (NCT NCT06628167)
NCT ID: NCT06628167
Last Updated: 2026-03-24
Results Overview
The Primary Outcome measures appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
252 participants
Primary outcome timeframe
12 months
Results posted on
2026-03-24
Participant Flow
Participant milestones
| Measure |
1. West Philadelphia CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
|
2. West Philadelphia Non CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
|
3. Southwest Philadelphia Residents
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
|
|---|---|---|---|
|
Overall Study
STARTED
|
34
|
105
|
113
|
|
Overall Study
COMPLETED
|
34
|
105
|
113
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Community Support Program for Lung Cancer Screening Volume II
Baseline characteristics by cohort
| Measure |
1. West Philadelphia CSP Participants
n=34 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
|
2. West Philadelphia Non CSP Participants
n=105 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
|
3. Southwest Philadelphia Residents
n=113 Participants
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
|
Total
n=252 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=138 Participants
|
0 Participants
n=62 Participants
|
0 Participants
n=123 Participants
|
0 Participants
n=158 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
34 Participants
n=138 Participants
|
105 Participants
n=62 Participants
|
113 Participants
n=123 Participants
|
252 Participants
n=158 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=138 Participants
|
0 Participants
n=62 Participants
|
0 Participants
n=123 Participants
|
0 Participants
n=158 Participants
|
|
Sex/Gender, Customized
Female
|
22 Participants
n=138 Participants
|
64 Participants
n=62 Participants
|
62 Participants
n=123 Participants
|
148 Participants
n=158 Participants
|
|
Sex/Gender, Customized
Male
|
12 Participants
n=138 Participants
|
39 Participants
n=62 Participants
|
51 Participants
n=123 Participants
|
102 Participants
n=158 Participants
|
|
Sex/Gender, Customized
Not Reported
|
0 Participants
n=138 Participants
|
2 Participants
n=62 Participants
|
0 Participants
n=123 Participants
|
2 Participants
n=158 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
1 Participants
n=138 Participants
|
0 Participants
n=62 Participants
|
1 Participants
n=123 Participants
|
2 Participants
n=158 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
33 Participants
n=138 Participants
|
88 Participants
n=62 Participants
|
111 Participants
n=123 Participants
|
232 Participants
n=158 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=138 Participants
|
17 Participants
n=62 Participants
|
1 Participants
n=123 Participants
|
18 Participants
n=158 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=138 Participants
|
2 Participants
n=62 Participants
|
1 Participants
n=123 Participants
|
3 Participants
n=158 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=138 Participants
|
0 Participants
n=62 Participants
|
2 Participants
n=123 Participants
|
2 Participants
n=158 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=138 Participants
|
0 Participants
n=62 Participants
|
0 Participants
n=123 Participants
|
0 Participants
n=158 Participants
|
|
Race (NIH/OMB)
Black or African American
|
33 Participants
n=138 Participants
|
99 Participants
n=62 Participants
|
92 Participants
n=123 Participants
|
224 Participants
n=158 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=138 Participants
|
2 Participants
n=62 Participants
|
13 Participants
n=123 Participants
|
15 Participants
n=158 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=138 Participants
|
0 Participants
n=62 Participants
|
0 Participants
n=123 Participants
|
0 Participants
n=158 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=138 Participants
|
2 Participants
n=62 Participants
|
5 Participants
n=123 Participants
|
8 Participants
n=158 Participants
|
|
Region of Enrollment
United States
|
34 participants
n=138 Participants
|
105 participants
n=62 Participants
|
113 participants
n=123 Participants
|
252 participants
n=158 Participants
|
|
Scheduled Lung Cancer Screening
|
34 Participants
n=138 Participants
|
105 Participants
n=62 Participants
|
113 Participants
n=123 Participants
|
252 Participants
n=158 Participants
|
PRIMARY outcome
Timeframe: 12 monthsThe Primary Outcome measures appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).
Outcome measures
| Measure |
1. West Philadelphia CSP Participants
n=34 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
|
2. West Philadelphia Non CSP Participants
n=105 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
|
3. Southwest Philadelphia Residents
n=113 Participants
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
|
|---|---|---|---|
|
Scheduled Lung Cancer Screening Appointments Attended by Participants
|
21 Participants
|
65 Participants
|
59 Participants
|
SECONDARY outcome
Timeframe: 12 monthsThe Secondary outcome is a measurement of the how many eligible participants (West Philadelphia residents) chose to opt into the CSP (as opposed to eligible participants who did not).
Outcome measures
| Measure |
1. West Philadelphia CSP Participants
n=139 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
|
2. West Philadelphia Non CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
|
3. Southwest Philadelphia Residents
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
|
|---|---|---|---|
|
CSP Enrollment
|
34 Participants
|
—
|
—
|
Adverse Events
1. West Philadelphia CSP Participants
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
2. West Philadelphia Non CSP Participants
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
3. Southwest Philadelphia Residents
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place